Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
Otsuka’s Alzheimer’s agitation drug hits the mark
antipsychotic drugs – which have been linked to a higher risk of death in dementia – as well as antidepressants and anxiety medications.
Latest news
-
Hidden health system costs: false positives and negatives
And maybe I suffer from some stress and anxiety. Or a false negative?
-
Sage raises $575m ahead of FDA review date for Zulresso
Unlike conventional antidepressants, which can take weeks to kick in, Zulresso starts working within two to three days of dosing and can lift women quickly out of the sadness, anxiety, irritability,
-
BMS isn’t phased by Opdivo’s slowing growth – for now
Lung cancer filing withdrawn after FDA reservations. Bristol-Myers Squibb’s fourth-quarter results showed a healthy sales increase for immuno-oncology blockbuster Opdivo, but there are signs that anxiety is
-
Moderna CEO makes case for firm’s lofty valuation
Moderna’s record-breaking $604m IPO last year was followed by a steep decline in its shares, which contributed to the anxiety about biotech sector financing overall in 2019, although Bancel
-
AstraZeneca wins NICE backing for asthma injection
hold them back from doing many basic daily tasks, lead to psychological problems including anxiety and depression, and leave them in constant fear of a potentially lethal asthma attack.
More from news
Approximately 1 fully matching, plus 143 partially matching documents found.
Latest Intelligence
-
Changing healthcare communications
Replacing anxiety with confidence, mediocrity with purpose. By David Hunt and Lou Shipley. ... But only if we replace anxiety with confidence, mediocrity with purpose, and attract the brightest, smartest and most creative minds to join our cause.
-
Drug launches to watch in 2019
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
-
AstraZeneca’s oncology renaissance
Galbraith is concerned about the rise in reported anxiety and mental health problems in young people, with young women most vulnerable.
-
The Patient Safety Challenge
There were anxieties about how reporting could affect their reputations and career prospects.
-
Finding the patient voice
This data provided the big picture about what motivates people to join clinical trials, their anxieties and their experiences. ... we should communicate with them, depending on their needs and anxieties.
More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
5 Ways to Communicate With Millennials About Healthcare
Being transparent adds authenticity, builds trust, and eases some anxieties that come with making important health decisions.
-
Artificial Intelligence in Healthcare
Stoking the fires of both patients’ and healthcare professionals’ (HCP) anxiety regarding the implementation of such a monumental system change are the hordes of drug makers who are beating on the
-
World Diabetes Day: Interaction and impact of diabetes on mental health
A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabetic medicine, 25(9), pp.1096-1101.
-
Neurodiversity, ADHD and work: Obstacles and opportunities
they generally persist through to adulthood, leading to on average worse educational, occupational, economic, social and relationship outcomes,[3] with higher rates of comorbidities such as mood, anxiety and sleep
-
Apple Watch Series 4: A life-saving tool or just making us more health obsessed?
I was once told that health anxiety (often known as hypochondriasis) is one of the most common types of anxiety. ... by its wearers in a negative fashion - instilling fear and anxiety in many.
More from PMHub
Approximately 0 fully matching, plus 20 partially matching documents found.
Featured jobs
-
Director – Healthcare PR
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
-
Account Director, Medical Education
-
Salary TBC
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
-
Senior Medical Writer
-
Competitive salary and benefits
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
-
Senior Medical Writer
-
Salary TBC
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Page & Page
Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
